Remove 2024 Remove Patient Care Remove Technology
article thumbnail

aycan becomes a reseller and technology partner of AI4MedImaging

DAIC

milla1cf Mon, 06/17/2024 - 20:34 June 17, 2024 — aycan , a recognized leader in medical imaging, announced today a reseller and technology partnership with AI4MedImaging, a company that specializes in applying artificial intelligence ( AI ) to medical imaging. and Germany.

article thumbnail

Penn Presbyterian Medical Center Becomes First Hospital in the Northeast to Adopt Advanced Robotic Technology for Heart Treatment

DAIC

milla1cf Thu, 05/30/2024 - 10:31 May 30, 2024 — Stereotaxis , a pioneer in surgical robotics for minimally invasive endovascular intervention, announced the successful treatment of the first heart rhythm patients by Penn Presbyterian Medical Center (PPMC) utilizing the advanced Genesis Robotic Magnetic Navigation System.

article thumbnail

RCE Technologies, Inc. Announces First-In-Human Transdermal Continuous Cardiac Biomarker Monitoring

DAIC

RCE Technologies, Inc. RCE) is an innovative artificial intelligence (AI) based medical technology company dedicated to early heart attack detection. milla1cf Mon, 04/22/2024 - 15:05 April 22, 2024 — At the annual American College of Cardiology conference ( ACC.24 Featured in an ACC.24 Featured in an ACC.24

article thumbnail

HRS 2024: Innovation Meets Reality

DAIC

Innovation in medical technology exists to improve patient outcomes, increase surgical efficiency and enhance patient safety. Infrequently, we see medical technology innovation of a paradigmatic nature that changes the way physicians approach disease states and dramatically improve results. So, again, innovation is great.

article thumbnail

Heart Rhythm Society’s HRX 2024 to Draw Cardiovascular Innovators to Atlanta

DAIC

The Heart Rhythm Society (HRS) is preparing for HRX 2024, the third annual event of its kind, which will be held from September 5-7, 2024, in Atlanta, GA, gathering cardiovascular health innovators together to explore discoveries and advance partnerships between medicine and technology. On Thursday, Sept.

article thumbnail

Ensight-AI Awarded FDA’s Breakthrough Device Designation for Its ECGVision-TTR Technology for Early Detection of ATTR-Cardiomyopathy

DAIC

Getty Images milla1cf Wed, 03/06/2024 - 18:45 March 6, 2024 — Ensight-AI , a Yale start-up and leader in AI -based cardiovascular diagnostics, announces the receipt of the U.S. Food and Drug Administration’s ( FDA ) Breakthrough Device Designation for their ECGvision-TTR Technology for early detection of ATTR-Cardiomyopathy.

article thumbnail

American Society of Echocardiography Scientific Sessions ASE 2024 Program Highlights

DAIC

June 4, 2024 — The countdown has begun ahead of the American Society of Echocardiography 35th Annual ASE Scientific Sessions, June 14-26, at the Oregon Convention Center in Portland, OR. The Program Chair for ASE 2024 is Federico Asch, MD, FASE, MedStar Health and Georgetown University (Wash.,